These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1796241)

  • 21. Incidence of HTLV-I in high-risk population in Delhi.
    Varma M; Mehta G
    J Commun Dis; 1999 Dec; 31(4):237-40. PubMed ID: 10937300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening of sera from the adult populations of some USSR regions for antibodies to the human T-cell leukemia virus type I (HTLV-I)].
    Seniuta NB; Iakovleva LS; Stepina VN; Buachidze LN; Gurova EP; Kologrivova ZA; Kindiakov VM; Gurtsevich VE
    Vopr Virusol; 1990; 35(4):309-12. PubMed ID: 2256315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual finding of HTLV-I infection among Amazonian Amerindians.
    Barros Kanzaki LI; Casseb J
    Arch Med Res; 2007 Nov; 38(8):897-900. PubMed ID: 17923274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroepidemiological survey of HTLV-I infection in French Polynesia, Cook Islands and Fiji.
    Chungue E; Boutin JP; Le Marchand L; Philippon G; Le Guellec A; Chanteau S; Cartel JL; Gras C; Martin PM; Roux JF
    Eur J Epidemiol; 1993 May; 9(3):347-50. PubMed ID: 8405324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Licensure of screening tests for antibody to human T-lymphotropic virus type I.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Dec; 37(48):736-40, 745-7. PubMed ID: 3143058
    [No Abstract]   [Full Text] [Related]  

  • 28. [HTLV-1 in a Mapuche population].
    Inostroza J; Díaz P; Saunier C
    Rev Med Chil; 1990 Dec; 118(12):1326-9. PubMed ID: 2152663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary study of HTLV-I seroprevalence in Chilean Indian populations].
    Cartier L; Tajima K; Araya F; Castillo JL; Zaninovic V; Hayami M; Imai J; Born P; Cárdenas M; Moreno J
    Rev Med Chil; 1993 Mar; 121(3):241-6. PubMed ID: 8248634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt.
    Constantine NT; Fathi Sheba M; Corwin AL; Danahy RS; Callahan JD; Watts DM
    Epidemiol Infect; 1991 Oct; 107(2):429-33. PubMed ID: 1936162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HTLV-I infection in sailors who travel to sub-Saharan West Africa].
    Pujol E; Ollero M; Márquez P; Gea A; Alcoucer R; Gimeno A
    Enferm Infecc Microbiol Clin; 1991 May; 9(5):283-5. PubMed ID: 1954264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
    Khameneh ZR; Baradaran M; Sepehrvand N
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of HTLV antibodies in wild-caught bonnet monkeys in southern India.
    Babu PG; Saraswathi NK; Ishida T; Mukundan P; John TJ
    Indian J Med Res; 1993 Sep; 97():183-6. PubMed ID: 7903281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibodies to HTLV-I in the sera of blood donors living in the republics of Central Asia and Kazakhstan].
    Seniuta NB; Iakovleva LS; Stepina VN; Pavlish OA; Syrtsev AV; Gurtsevich VE
    Vopr Virusol; 1991; 36(4):328-31. PubMed ID: 1839101
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiologic comparison of human T-lymphotropic virus type I-infected blood donors from endemic and nonendemic regions over a 3-year period.
    Massari V; Elghouzzi MH; Agis F; Rannou C; Gordien E; Costagliola D; Lefrère JJ
    Transfusion; 1994 Mar; 34(3):198-201. PubMed ID: 8146890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of antibodies interactive with HTLV-I antigens in selected Solomon Islands populations.
    Armstrong MY; Hrdy DB; Carlson JR; Friedlaender JS
    Am J Phys Anthropol; 1990 Apr; 81(4):465-70. PubMed ID: 2333936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-cell leukaemia/lymphoma virus risk may be enhanced in some selected donor populations.
    Price J; Cant BA; Barbara JA; Tedder RS
    Vox Sang; 2001 Apr; 80(3):148-50. PubMed ID: 11449953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance.
    Urwijitaroon Y; Barusrux S; Puapairoj C; Romphruk A; Khampeera P
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S102-5. PubMed ID: 9347655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevalence of human T-lymphotropic virus, Type 1 and 2 in blood donors and patients with sexually transmissible diseases in Surinam].
    Alberga H; Goubau P; Desmyter J; Carton H
    Ned Tijdschr Geneeskd; 1996 Aug; 140(33):1689-92. PubMed ID: 8830293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.